“…Importantly, this is the value considered by ISO 10993-5 (ISO, 2009) as the level below which a toxic effect is assumed to occur. Although not directly proposed herein as matrix material per se, unmodified LBG was also tested, because its application in drug delivery has been reported, in many occasions addressing oral delivery strategies (Colombo et al, 1990;Conte & Maggi, 1996;Coviello, Alhaique, Dorigo, Matricardi & Grassi, 2007;Dey, Sa & Maiti, 2015; Jana, Gandhi, Sheet & Sen, 2015;Malik, Arora & Singh, 2011a;Malik, Arora & Singh, 2011b;Ngwuluka, Choonara, Kumar, du Toit, Modi & Pillay, 2015;Sandolo, Coviello, Matricardi & Alhaique, 2007;Sujja-areevath, Munday, Cox & Khan, 1998;Syed, Mangamoori & Rao, 2010;Tobyn, Staniforth, Baichwal & McCall, 1996), but data on its effect on epithelial cells are not available in the literature. Moreover, a comparison between bulk LBG and purified LBG was performed, revealing no significant differences, which indicates an absence of effect of the purification process in the cytotoxic profile of the material.…”